A groundbreaking study by researchers from the Universities of Basel and Zurich has unlocked one of the most significant ...

This is the first time we’ve had access to an influenza genome from the 1918–1920 pandemic in Switzerland. It opens up new insights into the dynamics of how the virus adapt ...

Yuta Tsukamoto et. al. Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication. Science, 2023 DOI: 10.1126/science.add0875 ...

Influenza requires cellular enzyme for replication The enzyme MTr1 provides cellular mRNA with a cap structure and thus functions as the cell's "nucleic acid labeler".

Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA) protein head. The ...

Influenza is a common respiratory virus that is categorized into four types: A, B, C and D. Type C only causes mild infections and type D is not believed to infect humans.

Vaccines remain the best defense against COVID-19 and influenza, with the flu vaccine mainly targeting two proteins on the virus’s surface. Researchers in ACS Central Science report that simulations ...

Avian influenza A(H5N1) virus is spreading through dairy herds across the United States. In this report, wastewater surveillance shows the increase of H5N1 across 10 urban communities.

Highly pathogenic avian influenza A(H5N1) viruses are circulating among wild birds and poultry in British Columbia, Canada. 1 These viruses are also recognized to cause illness in humans. Here, we ...